J. Clarke

发表

Multi-targeted prevention of cancer by sulforaphane.

E. Ho, R. Dashwood, J. Clarke, 2008, Cancer letters.

MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period.

J. Aldan, Katherine D. Lynch, J. A. Baron, 2021, Toxicology.

Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats

Michael J Goedken, Katherine D. Lynch, T. Arman, 2019, Toxins.

Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol diet.

Michael J Goedken, Katherine D. Lynch, T. Arman, 2020, Chemosphere.

Nonalcoholic fatty liver disease alters microcystin‐LR toxicokinetics and acute toxicity

N. Cherrington, M. Paine, A. Dzierlenga, 2019, Toxicon : official journal of the International Society on Toxinology.

In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice

N. Cherrington, J. Bear, Michael J Goedken, 2017, Journal of biochemical and molecular toxicology.

Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models

April D. Lake, N. Cherrington, R. Hardwick, 2014, Drug Metabolism and Disposition.

Special Section on Transporters in Toxicity and Disease Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models s

N. Cherrington, R. Hardwick, A. Dzierlenga, 2014 .

DMD055996 586..595

N. Cherrington, A. Dzierlenga, Rhiannon N Hardwick, 2014 .

Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions

N. Cherrington, J. Clarke, J. Clarke, 2012, Expert opinion on drug metabolism & toxicology.

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis

D. Billheimer, R. Erickson, N. Cherrington, 2017, Drug Metabolism and Disposition.

Renal Xenobiotic Transporter Expression is Altered in Multiple Experimental Models of Nonalcoholic Steatohepatitis

April D. Lake, N. Cherrington, A. Dzierlenga, 2015, Drug Metabolism and Disposition.

Synergistic interaction between genetics and disease on pravastatin disposition.

C. Klaassen, April D. Lake, N. Cherrington, 2014, Journal of hepatology.

Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans

T. Arman, J. Clarke, J. Clarke, 2021, Toxins.

Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression

April D. Lake, N. Cherrington, R. Hardwick, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Selective and Cytokine-Dependent Regulation of Hepatic Transporters and Bile Acid Homeostasis during Infectious Colitis in Mice

N. Cherrington, E. Morgan, Beatrice A. Nyagode, 2014, Drug Metabolism and Disposition.

Special Section on Transporters in Toxicity and Disease Selective and Cytokine-Dependent Regulation of Hepatic Transporters and Bile Acid Homeostasis during Infectious Colitis in Mice s

N. Cherrington, E. Morgan, Beatrice A. Nyagode, 2014 .

Gene-by-Environment Interaction of Bcrp−/− and Methionine- and Choline-Deficient Diet–Induced Nonalcoholic Steatohepatitis Alters SN-38 Disposition

N. Cherrington, Michael J Goedken, Anna Vildhede, 2018, Drug Metabolism and Disposition.

Involvement of the p38/MK2 Pathway in MCLR Hepatotoxicity Revealed through MAPK Pharmacological Inhibition and Phosphoproteomics in HepaRG Cells

B. Prasad, Katherine D. Lynch, J. Clarke, 2023, International journal of molecular sciences.

Interaction of Oatp1b2 Expression and Nonalcoholic Steatohepatitis on Pravastatin Plasma Clearance.

N. Cherrington, I. Csanaky, J. Clarke, 2019, Biochemical pharmacology.

Impaired N‐linked glycosylation of uptake and efflux transporters in human non‐alcoholic fatty liver disease

April D. Lake, P. Novák, N. Cherrington, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.

E. Ho, R. Dashwood, J. Clarke, 2009, The Journal of nutrition.

Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.

E. Ho, R. Dashwood, A. Hsu, 2011, Molecular nutrition & food research.

A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model

M. Paine, B. Hagenbuch, Katherine D. Lynch, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Broccoli Sprouts Delay Prostate Cancer Formation and Decrease Prostate Cancer Severity with a Concurrent Decrease in HDAC3 Protein Expression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice

David E. Williams, E. Ho, L. Beaver, 2017, Current developments in nutrition.

Broccoli sprouts delay prostate cancer formation and decrease prostate cancer severity with a concurrent decrease in HDAC3 protein expression in TRAMP mice.

David E. Williams, E. Ho, L. Beaver, 2017 .

Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability.

N. Cherrington, J. Clarke, J. Clarke, 2015, Pharmacology & therapeutics.

Modeling Pharmacokinetic Natural Product–Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach

A. Rettie, J. Unadkat, J. McCune, 2021, Pharmacological Reviews.

Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.

S. Snyder, T. Anumol, April D. Lake, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

Circulating microRNA 122 in the methionine and choline‐deficient mouse model of non‐alcoholic steatohepatitis

E. Blomme, April D. Lake, N. Cherrington, 2014, Journal of applied toxicology : JAT.

Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.

N. Cherrington, Michael J Goedken, A. Dzierlenga, 2016, Biochemical pharmacology.